The global pruritus therapeutics market is
anticipated to reach over USD 17,275.12 Million by 2026, according to a new
research published by Polaris Market Research, Pruritus, also known as itch
disorder can be triggered by several ailments ranging from dermatological
disorders such as mycoses, atopic dermatitis, chickenpox, and contact
dermatitis, Pruritus is interrelated with the dermatologic and systemic causes.
A typical itching generally forms the diagnosis of a key dermatologic syndrome.
Several skin diseases that are related to pruritus include renal pruritus,
hematologic pruritus, cholestatic pruritus, idiopathic generalized pruritus,
pruritus related to malignancy and endocrine pruritus. Renal pruritus can
befall in people with chronic renal failure. Increased levels of ions such as
calcium, phosphate, and magnesium are found in the skin of pruritic patients.
Severe pruritus leads to scratching that causes secondary skin problems
such as eczematization, dryness, infection, excoriation, Contact allergy, and
lichenification.
Some major key players in global
Pruritus Therapeutics Market include pruritus therapeutics market
includes Allergan Inc., Amgen Inc., Astellas Pharma Inc., CARA
Therapeutics, Novartis AG, and Teva Pharmaceutical Industries Ltd. among
others.
Get Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/global-pruritus-therapeutics-market/request-for-sample
The rising incidence of
dermatological disorder influencing the occurrence of pruritus and
subsequently, the rising demand for proper diagnostics as well as therapeutics
to treat the such medical condition is anticipated to bolster the market
growth. The rise in inorganic development strategies is recognized as one of
the key factor boosting the growth of the pruritus therapeutic market. In
addition, the key players of the pruritus therapeutic market are progressively
adapting the growth strategies such as partnerships, regional acquirements, and
mergers and acquisitions. Such growth strategies are anticipated to result in
technological advancement owing to enhancement in the product portfolio and
mutual collaboration in R&D further boosting the market growth.
The global pruritus therapeutics
market is segmented on the basis of product, disease type, and geography. On
the basis of product, the global pruritus therapeutics market is segmented into
Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant,
Calcineurin Inhibitors, and Others. In 2017, the corticosteroids are expected
to dominate the market by product segment as corticosteroids are widely used as
the first line of treatment. On the basis of disease type, the global pruritus
therapeutics market is segmented into Atopic Dermatitis, Allergic Contact
Dermatitis, Urticaria, and Others. In 2017, Allergic contact dermatitis is
estimated to dominate the market segment. It is the 3rd most general cause for
patients seeking consultation with a dermatology specialist. Allergic contact
dermatitis is commonly observed in women.
Special Discount Offer on Complete Report @ https://www.polarismarketresearch.com/industry-analysis/global-pruritus-therapeutics-market/request-for-discount-pricing
On the basis of region, the global
pruritus therapeutics market is segmented into North America, Europe, Asia
Pacific, Latin America, and Middle East & Africa. North America was
estimated to dominate the global pruritus therapeutics market. The dominance is
majorly due to The presence of favorable government initiatives and the
introduction of new products. Moreover, rising incidence of target disorders
and the existence of pruritus inducing climatic disorders in this region are
anticipated to boost the market growth during the forecast period. However,
Asia Pacific is anticipated to dominate pruritus therapeutics market. Growing
incidence of atopic dermatitis and urticarial and presence of unmet healthcare
organization needs are the factors attributed to the growth of the market in
Asia Pacific.
Contact Us
Polaris Market
Research & Consulting
Phone:
1-646-568-9980
Email:
sales@polarismarketresearch.com
No comments:
Post a Comment
Please do not enter any spam link in the comment box...